IDA blend vs Syria: Cause of death, by non-communicable diseases, ages 60+, male
IDA blend
65.6%
in 2021
Syria
82.8%
in 2021
IDA blend rank
28th
Syria rank
28th
Cause of death, by non-communicable diseases, ages 60+, male over time
- IDA blend
- Syria
How they compare
Syria currently reports 82.8% against 65.6% in IDA blend, a difference of 17.2%.
That makes Syria's figure about 1.3 times IDA blend's.
Across all 6 years both countries report, Syria has been ahead every year.
IDA blend ranks 28th and Syria ranks 28th of 47 groups.
Syria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA blend | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 70.3% | 95.1% | 24.8% | Syria |
| 2010s | 75.3% | 92.0% | 16.7% | Syria |
| 2020s | 67.4% | 86.3% | 18.9% | Syria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, male, IDA blend or Syria?
- Syria, at 82.8% against 65.6% in IDA blend as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, male between IDA blend and Syria?
- 17.2%, with Syria ahead.
- How many years of comparable data are there for IDA blend and Syria?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA blend and Syria rank globally for cause of death, by non-communicable diseases, ages 60+, male?
- IDA blend ranks 28th and Syria ranks 28th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, male (% of total male deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 60+ due to non-communicable diseases divided by number of all male deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.